Bone targeted therapy in breast cancer: present and future

Crit Rev Oncol Hematol. 2010 Apr:74 Suppl 1:S7-10. doi: 10.1016/S1040-8428(10)70004-4.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • Bone Density Conservation Agents / therapeutic use*
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / secondary*
  • Bone and Bones / drug effects*
  • Bone and Bones / pathology
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / pathology*
  • Denosumab
  • Diphosphonates / therapeutic use*
  • Drug Delivery Systems
  • Female
  • Humans
  • RANK Ligand / therapeutic use*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Bone Density Conservation Agents
  • Diphosphonates
  • RANK Ligand
  • Denosumab